Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1997 Feb;52(2):143–148. doi: 10.1136/thx.52.2.143

Nasal responsiveness to allergen and histamine in patients with perennial rhinitis with and without a late phase response

Vel C de Graaf-in't, I M Garrelds, A W van Toorenenberge, v Gerth
PMCID: PMC1758482  PMID: 9059474

Abstract

BACKGROUND: In the lower airways an association has been found between early phase reaction (EPR), late phase reaction (LPR), and bronchial hyperreactivity. However, this association has not been shown for the upper airways in nasal pollen challenge studies. A study was undertaken to determine whether the EPR, LPR, and nasal hyperreactivity are related in perennial allergic rhinitis. METHODS: Twenty four patients with rhinitis who were allergic to house dust mite (HDM) were challenged with HDM extract. The nasal response was monitored by symptom scores and nasal lavages for up to 9.5 hours after challenge and concentrations of albumin, tryptase, and eosinophil cationic protein (ECP) in the lavage fluid were measured. Thirteen patients (defined as dual responders) had increased symptom scores between 3.5 and 9.5 hours compared with the baseline score. The other 11 patients (defined as early responders) showed an isolated EPR only. Nasal hyperreactivity was determined by nasal histamine challenge 24 hours later. RESULTS: Dual responders showed a significantly higher symptom score, albumin influx, and tryptase release during the EPR. During the late phase (3.5-9.5 hours) albumin influx was significantly increased at most time points and ECP release was significantly higher at 9.5 hours in the dual responder group. Dual responders showed a significantly stronger response to all doses of histamine. The area under the curve (AUC) of symptom scores during EPR and LPR and the AUC of the histamine dose response were significantly correlated (EPR-LPR: r = 0.49, p < 0.01; EPR-histamine: r = 0.75, p < 0.001; LPR-histamine: r = 0.66, p < 0.001). CONCLUSIONS: In patients with perennial allergic rhinitis the nasal responses to allergen and histamine are associated. Dual responders have an increased EPR, increased levels of mediators, and increased allergen-induced hyperreactivity. 




Full Text

The Full Text of this article is available as a PDF (127.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson M., Andersson P., Pipkorn U. Allergen-induced specific and non-specific nasal reactions. Reciprocal relationship and inhibition by topical glucocorticosteroids. Acta Otolaryngol. 1989 Mar-Apr;107(3-4):270–277. doi: 10.3109/00016488909127508. [DOI] [PubMed] [Google Scholar]
  2. Bascom R., Pipkorn U., Lichtenstein L. M., Naclerio R. M. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis. 1988 Aug;138(2):406–412. doi: 10.1164/ajrccm/138.2.406. [DOI] [PubMed] [Google Scholar]
  3. Baumgarten C. R., Togias A. G., Naclerio R. M., Lichtenstein L. M., Norman P. S., Proud D. Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest. 1985 Jul;76(1):191–197. doi: 10.1172/JCI111945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borum P. Nasal methacholine challenge. A test for the measurement of nasal reactivity. J Allergy Clin Immunol. 1979 Apr;63(4):253–257. doi: 10.1016/0091-6749(79)90109-x. [DOI] [PubMed] [Google Scholar]
  5. Cartier A., Thomson N. C., Frith P. A., Roberts R., Hargreave F. E. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol. 1982 Sep;70(3):170–177. doi: 10.1016/0091-6749(82)90038-0. [DOI] [PubMed] [Google Scholar]
  6. Cockcroft D. W. Mechanism of perennial allergic asthma. Lancet. 1983 Jul 30;2(8344):253–256. doi: 10.1016/s0140-6736(83)90235-0. [DOI] [PubMed] [Google Scholar]
  7. Cockcroft D. W., Ruffin R. E., Dolovich J., Hargreave F. E. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy. 1977 Nov;7(6):503–513. doi: 10.1111/j.1365-2222.1977.tb01481.x. [DOI] [PubMed] [Google Scholar]
  8. Connell J. T. Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane. J Allergy. 1968 Mar;41(3):123–139. doi: 10.1016/0021-8707(68)90053-1. [DOI] [PubMed] [Google Scholar]
  9. De Monchy J. G., Kauffman H. F., Venge P., Koëter G. H., Jansen H. M., Sluiter H. J., De Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis. 1985 Mar;131(3):373–376. doi: 10.1164/arrd.1985.131.3.373. [DOI] [PubMed] [Google Scholar]
  10. Durham S. R., Craddock C. F., Cookson W. O., Benson M. K. Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses. J Allergy Clin Immunol. 1988 Nov;82(5 Pt 1):764–770. doi: 10.1016/0091-6749(88)90077-2. [DOI] [PubMed] [Google Scholar]
  11. Ferguson H., Davies R. J. Late phase nasal reactions--reviewed and revisited. Respir Med. 1991 May;85(3):247–249. doi: 10.1016/s0954-6111(06)80089-2. [DOI] [PubMed] [Google Scholar]
  12. Grønborg H., Borum P., Mygind N. Histamine and methacholine do not increase nasal reactivity. Clin Allergy. 1986 Nov;16(6):597–602. doi: 10.1111/j.1365-2222.1986.tb01999.x. [DOI] [PubMed] [Google Scholar]
  13. Iliopoulos O., Proud D., Adkinson N. F., Jr, Creticos P. S., Norman P. S., Kagey-Sobotka A., Lichtenstein L. M., Naclerio R. M. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol. 1991 Apr;87(4):855–866. doi: 10.1016/0091-6749(91)90134-a. [DOI] [PubMed] [Google Scholar]
  14. Klementsson H., Andersson M., Baumgarten C. R., Venge P., Pipkorn U. Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge. Clin Exp Allergy. 1990 Sep;20(5):539–547. doi: 10.1111/j.1365-2222.1990.tb03147.x. [DOI] [PubMed] [Google Scholar]
  15. Lebel B., Bousquet J., Morel A., Chanal I., Godard P., Michel F. B. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol. 1988 Nov;82(5 Pt 1):869–877. doi: 10.1016/0091-6749(88)90092-9. [DOI] [PubMed] [Google Scholar]
  16. Naclerio R. M., Meier H. L., Kagey-Sobotka A., Adkinson N. F., Jr, Meyers D. A., Norman P. S., Lichtenstein L. M. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983 Oct;128(4):597–602. doi: 10.1164/arrd.1983.128.4.597. [DOI] [PubMed] [Google Scholar]
  17. Naclerio R. M., Proud D., Togias A. G., Adkinson N. F., Jr, Meyers D. A., Kagey-Sobotka A., Plaut M., Norman P. S., Lichtenstein L. M. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11;313(2):65–70. doi: 10.1056/NEJM198507113130201. [DOI] [PubMed] [Google Scholar]
  18. Pastorello E. A., Riario-Sforza G. G., Incorvaia C., Segala M., Fumagalli M., Gandini R. Comparison of rhinomanometry, symptom score, and inflammatory cell counts in assessing the nasal late-phase reaction to allergen challenge. J Allergy Clin Immunol. 1994 Jan;93(1 Pt 1):85–92. doi: 10.1016/0091-6749(94)90236-4. [DOI] [PubMed] [Google Scholar]
  19. Schwartz L. B. Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells. J Immunol. 1985 Jan;134(1):526–531. [PubMed] [Google Scholar]
  20. Small P., Biskin N., Barrett D. Effects of intensity of early response to allergen on the late phase of both the nose and skin. Ann Allergy. 1994 Sep;73(3):252–258. [PubMed] [Google Scholar]
  21. Svensson C., Baumgarten C. R., Pipkorn U., Alkner U., Persson C. G. Reversibility and reproducibility of histamine induced plasma leakage in nasal airways. Thorax. 1989 Jan;44(1):13–18. doi: 10.1136/thx.44.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Svensson C., Pipkorn U., Alkner U., Baumgarten C. R., Persson C. G. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy. 1992 Mar;22(3):411–416. doi: 10.1111/j.1365-2222.1992.tb03103.x. [DOI] [PubMed] [Google Scholar]
  23. Wang D., Clement P., Smitz J., De Waele M., Derde M. P. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol. 1995 Mar;106(3):278–285. doi: 10.1159/000236855. [DOI] [PubMed] [Google Scholar]
  24. van Wijk R. G., van Toorenenbergen A. W., Zijlstra F. J., Jansen A. P., Dieges P. H. Nasal hyperreactivity and its effect on early and late sequelae of nasal challenge with house-dust mite extract. Allergy Proc. 1993 Jul-Aug;14(4):273–281. doi: 10.2500/108854193778812026. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES